RT Book, Section
A1 Drachman, Daniel B.
A1 Amato, Anthony A.
A2 Kasper, Dennis
A2 Fauci, Anthony
A2 Hauser, Stephen
A2 Longo, Dan
A2 Jameson, J. Larry
A2 Loscalzo, Joseph
SR Print(0)
ID 1128503226
T1 Myasthenia Gravis and Other Diseases of the Neuromuscular Junction
T2 Harrison's Principles of Internal Medicine, 19e
YR 2014
FD 2014
PB McGraw-Hill Education
PP New York, NY
SN 9780071802154
LK accesspharmacy.mhmedical.com/content.aspx?aid=1128503226
RD 2020/11/24
AB Myasthenia  gravis  (MG)  is  a  neuromuscular  disorder  characterized  by  weakness  and  fatigability  of  skeletal  muscles.  The  underlying  defect  is  a  decrease  in  the  number  of  available  acetylcholine  receptors  (AChRs)  at  neuromuscular  junctions  due  to  an  antibody-mediated  autoimmune  attack.  Treatment  now  available  for  MG  is  highly  effective,  although  a  specific  cure  has  remained  elusive.